Related Experiment Video
Updated: Aug 8, 2026

Microfluidic Applications for Disposable Diagnostics
Published on: February 3, 2008
Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric
Rama S Sista1, Rainer Ng1, Miriam Nuffer1
1Baebies, Inc., PO Box 14403, Durham, NC 27709, USA.
Insights
Pediatric diagnostic blood testing now uses a novel microfluidic platform to perform various assays with minimal blood samples. This technology addresses iatrogenic anemia in children by providing rapid, customized results.
Area of Science:
- Biomedical Engineering
- Pediatric Diagnostics
- Microfluidics
Background:
- Pediatric patients, especially newborns, have unique physiological needs distinct from adults.
- Current diagnostic blood testing practices in children can lead to iatrogenic anemia due to excessive blood draw volumes.
- Existing rapid testing platforms for adults are not always optimized for pediatric clinical relevance or sample volumes.
Purpose of the Study:
- To develop and validate a digital microfluidic platform for pediatric diagnostic testing.
- To address the limitations of current blood testing methods in children, focusing on reduced sample volume and customized assays.
- To enable rapid, near-patient testing with clinically relevant assays for newborns and pediatric patients.
Main Methods:
- Development of an automated digital microfluidic platform utilizing electrowetting for precise nanoliter droplet manipulation.
- Creation of single-use cartridges containing all necessary reagents for sample preparation and assay performance.
- Automation of diverse assay types including biochemical, immunoassays, and molecular assays, requiring minimal user intervention.
Main Results:
- Successful automation of over two dozen unique tests on the platform, including cell lysis, plasma preparation, and thermocycling.
- Assays demonstrated performance comparable to standard clinical laboratory methods.
- The platform utilizes microliter sample volumes (<50 µL), significantly reducing blood loss and enabling simultaneous testing.
Conclusions:
- The developed digital microfluidic platform offers a viable solution for customized pediatric diagnostic testing.
- This technology minimizes iatrogenic anemia risk in children by requiring substantially reduced sample volumes.
- The platform provides economical, rapid, and versatile testing capabilities crucial for neonatal and pediatric care.
Abstract:
"Children are not tiny adults" is an adage commonly used in pediatrics to emphasize the fact that children often have different physiological responses to sickness and trauma compared to adults. However, despite widespread acceptance of this concept, diagnostic blood testing is an excellent example of clinical care that is not yet customized to the needs of children, especially newborns. Cumulative blood loss resulting from clinical testing does not typically impact critically ill adult patients, but can quickly escalate in children, leading to iatrogenic anemia and related comorbidities. Moreover, the tests prioritized for rapid, near-patient testing in adults are not always the most clinically relevant tests for children or newborns. This report describes the development of a digital microfluidic testing platform and associated clinical assays purposely curated to address current shortcomings in pediatric laboratory testing by using microliter volumes (<50 µL) of samples. The automated platform consists of a small instrument and single-use cartridges, which contain all reagents necessary to prepare the sample and perform the assay. Electrowetting technology is used to precisely manipulate nanoliter-sized droplets of samples and reagents inside the cartridge. To date, we have automated three disparate types of assays (biochemical assays, immunoassays, and molecular assays) on the platform and have developed over two dozen unique tests, each with important clinical application to newborns and pediatric patients. Cell lysis, plasma preparation, magnetic bead washing, thermocycling, incubation, and many other essential functions were all performed on the cartridge without any user intervention. The resulting assays demonstrate performance comparable to standard clinical laboratory assays and are economical due to the reduced hands-on effort required for each assay and lower overall reagent consumption. These capabilities allow a wide range of assays to be run simultaneously on the same cartridge using significantly reduced sample volumes with results in minutes.
More Related Videos
11:32A Microfluidic Platform for Precision Small-volume Sample Processing and Its Use to Size Separate Biological Particles with an Acoustic Microdevice
Published on: November 23, 2015
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017